Awiqli

Awiqli is a subcutaneous medication containing Insulin Icodec, designed for managing blood glucose levels in diabetes. This long-acting insulin analog offers a convenient once-weekly administration option for adults with type 2 diabetes.

Awiqli is primarily used for the management of type 2 diabetes in adults. It works by mimicking the action of natural insulin, helping to regulate blood sugar levels. This medication is often prescribed as part of a comprehensive diabetes management plan, which may include diet and exercise. Awiqli is designed for subcutaneous use, providing a long-acting insulin effect to help control glucose levels over an extended period.

Awiqli may cause common effects such as injection site reactions, weight gain, and hypoglycemia. Some users may experience fatigue, headache, or gastrointestinal issues. It is important to monitor blood sugar levels regularly while using this medication to manage any potential side effects effectively.

Awiqli should be handled with care, ensuring proper storage and administration as directed. It is important to inform healthcare providers about any allergies or medical conditions before starting this medication. Regular monitoring of blood glucose levels is recommended to avoid potential complications. Always follow the prescribed dosage and administration guidelines to ensure safe and effective use.

Awiqli may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption should be moderated, as it can affect blood sugar levels. It is advisable to consult with a healthcare provider before combining Awiqli with other medications or supplements to avoid potential interactions.